We are a diverse group of physicians & scientists with expertise in cell biology, pharmacology, genetics, immunology and computational biology. If you would like to join our team, please contact us.
Aaron received his MD and Ph.D. degrees at Vanderbilt University in Nashville TN, where he studied the structure and function of prostaglandin receptors in the laboratory of Dr. Richard Breyer in the Department of Pharmacology. He completed an Internal Medicine residency at Brigham and Women’s Hospital in Boston, followed by a Medical Oncology fellowship at Dana Farber Cancer Institute and Massachusetts General Hospital. He performed his post-doctoral research in the laboratory of Dr. Jeffrey Engelman in the MGH Cancer Center, where he focused on understanding mechanisms of drug sensitivity and resistance to targeted therapies for lung cancer. In 2016, he joined the MGH Cancer Center faculty as principal investigator.
Hematology and Oncology, Massachusetts General Hospital
Harvard Medical School
Broad Institute
Toshio joined the Hata Lab in April 2022. He received his MD at Nagoya City University, Japan and practiced as a thoracic surgeon in Japan, where he developed a great interest in cancer biology. He then obtained his Ph.D. at Kindai University, Japan, where he studied the resistance mechanism to MET-TKIs in lung cancer harboring MET exon 14 skipping mutation in the laboratory of Dr. Tetsuya Mitsudomi. Toshio is currently focusing…
Jamie completed his Bachelor and Masters at the University of Sussex, before undertaking his PhD at the University College London. There he worked with Professors Benjamin Chain and Mahdad Noursadeghi, developing methods for high-throughput sequencing and analysis of T cell receptor (TCR) repertoires. He moved from London to MGH to work with Mark Cobbold, exploring immunopeptidomes and TCR repertoires in a range of cancers. Staying within the department, he moved…
Hideko joined the Hata Lab in June 2017. She completed Ph.D. at Okayama University in the Department of Hematology, Oncology and Respiratory Medicine where she focused on the mechanisms of drug resistance to molecularly target inhibitor in lung cancer harboring the EML4-ALK fusion gene. A number of mechanisms of drug resistance to target therapy have been identified such as her previous study, yet little is know what’s happening on during…
In 2024, Divya joined Hata Lab after earning her Master's in Biology from the Indian Institute of Science Education & Research, Trivandrum, India, and completing her Ph.D. in health sciences at Ben-Gurion University of the Negev, Israel, under Prof. Etta Livneh. In Prof. Livneh's lab, she discovered a novel mechanism regulating PKC activity through an upstream ORF-encoded peptide, revealing its significance in cancer therapy. Her study showed a uORF with…
Radhika joined the Hata lab in 2022. She did her Masters in Virology from the National Institute of Virology, India. Radhika received PhD in Cell and Molecular biology from the University of Toledo, Ohio. During her graduate school in Dr. William R. Taylor lab her research focused on the spindle assembly checkpoint and mitotic spindle architecture. In the Hata lab she is working on understanding the role of tumor micro-environment…
Chendi received her Bachelor of Science degree in Biological Science as an honors graduate from Shaanxi Normal University, China. She then completed a PhD in the Department of Biochemistry at Boston University School of Medicine (BUSM) where her research in the laboratory of Dr. Stephen Farmer focused on understanding the mechanisms of energy expenditure and stem cell fate in brown adipose tissue. Chendi joined the Hata laboratory as a research…
In April 2024, Takashi became a member of the Hata lab. He received his MD from Tsukuba University, Japan, and has been working as a thoracic surgeon. He developed an interest in cancer biology related to thoracic malignancies while working. His research focused on the tumor microenvironment of NSCLC at the National Cancer Center, Japan, and Toho University in Japan, and he finished his PhD at Toho University under the…
Ishmarie joined the Hata lab in June of 2023 after completing her BS in Biomedical Sciences at the University of South Florida. At USF, she worked in the Davila and Locke labs studying the development of gene-engineered cell therapies targeting cancer cells in preclinical models. In the Hata lab, she works with Jamie studying the development of immunotherapies to treat ALK+ lung cancer. She hopes to later pursue a Ph.D.…
Emily joined the Hata Lab in June 2022 after receiving her BA from College of the Holy Cross. At Holy Cross, Emily was a Biology/Chinese double major, and worked in Dr. Alexis Hill's Drosophila Neurobiology lab. Her work focused on the gene seizure (sei) and how it affects developmental time in Drosophila, along with determining which cell types express sei. In the Hata lab, she is a member of the Model Development Team which seeks to create cell…
Lauren joined the Hata Lab in August 2023 after completing her B.A. in Biology from the University of Virginia. During her time at UVA, Lauren worked as a Certified Nursing Assistant for UVA Health and as a scribe for Shenandoah Valley Orthopedics & Sports Medicine. In the Hata Lab, Lauren is part of the Model Development Team and hopes to pursue a career in medicine in the future. Outside of…
Grace joined the Hata lab in July 2022 after earning her BS in Biology from Providence College with a minor in Community Health. During her undergraduate studies, she worked in the Silvestrini Lab studying the role of autophagy using the model organism C. elegans. She also worked as a Certified Nursing Assistant in a memory care unit. In the Hata lab, she is a member of the Model Development team. Outside…
Arjun joined the Hata Lab in December 2023 after receiving his BA from Brown University. At Brown, Arjun was a Biology/Economics double major, and worked in biopharmaceutical investment banking at Leerink Partners in New York after graduation. He worked across M&A and equity capital markets for early-stage, preclinical biotech and pharmaceutical companies. In the Hata lab, he is a member of the Model Development Team which seeks to create cell…
Katie joined the Hata lab in December 2021 after earning her BS/MS in Biology from Tufts University. At Tufts, she conducted undergraduate research with Julia Gouvea, studying the learning and teaching practices of Biology at multiple grade levels. Dr. Gouvea's research investigates how model-based reasoning as a biological practice can support deeper learning for students. In the Hata lab, Katie works with Samar on identifying therapeutic strategies for KRAS NSCLS.…
Jamie joined the Hata Lab in February 2024 after completing her BS in Molecular, Cellular, and Developmental Biology at the University of Washington. While completing her studies, she was a member of the Fuller Lab, where she studied viral pathogenesis and the development of antivirals, vaccines, and immunotherapies. She also was a member of the Iribarren research group, where she worked on developing a urine metabolite test for tuberculosis drug…